LIM/31 (Laboratório de Investigação Médica em Patogênese e Terapia dirigida em Onco-Imuno-Hematologia) e no Centro de Investigação Translacional em Oncologia (CTO/ICESP) no complexo do HCFMUSP. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Acute Myeloid Leukemia (AML) is a malignant hematological disorder driven by unregulated proliferation and impaired differentiation of myeloid progenitor cells. The most common treatment for AML is the conventional chemotherapy based on the combination of an anthracycline and cytarabine, leading to several side effects, which may affect the treatment progress. To design new therapeutic ap…
Acute myeloid leukaemia (AML) is a malignant haematological disorder caused by uncontrolled proliferation and impaired differentiation of myeloid progenitor cells. Recent studies suggest that not only intrinsic mutations drive leukemogenesis but that the bone marrow (BM) microenvironment can facilitate the expansion of leukemic cells. Hence, new therapeutic approaches that target both the…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 2 / 2 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID